Efficacy of pramipexole on quality of life in patients with Parkinson’s disease: a systematic review and meta-analysis

BACKGROUND: Quality of life (QoL) in patients with Parkinson’s disease (PD) is increasingly used as an efficacy outcome in clinical studies of PD to evaluate the impact of treatment from the patient’s perspective. Studies demonstrating the treatment effect of pramipexole on QoL remain inconclusive....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Zou, Shuang, Zhang, Zijuan, Liu, Meiruo, Liang, Zhanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404654/
https://www.ncbi.nlm.nih.gov/pubmed/36008796
http://dx.doi.org/10.1186/s12883-022-02830-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404654/
https://www.ncbi.nlm.nih.gov/pubmed/36008796
http://dx.doi.org/10.1186/s12883-022-02830-y

Ejemplares similares